All Articles

Prognostic value of lymphocyte subset levels in hepatocellular carcinoma following conventionally fractionated vs. stereotactic body radiotherapy

Sex differences in hepatocellular carcinoma

Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy

Activator protein-1 in liver pathology: from precancerous diseases to hepatocellular carcinoma

Local and systemic thrombotic complications in cirrhotic patients with hepatocellular carcinoma

Radioembolization for hepatocellular carcinoma: updated strategies and evolving clinical applications

Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article

Radiotherapy efficacy and prognostic factors in hepatocellular carcinoma patients with cardiophrenic angle or superior diaphragmatic lymph nodes metastasis

Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer

Advances in radiomics applications for intrahepatic cholangiocarcinoma: a comprehensive review and future directions

Hepatocellular carcinoma recurrence after liver transplantation: risk factors, targeted surveillance and management options

The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

Transarterial intervention therapy combined with systemic therapy for HCC: a review of recent five-year articles

MASLD: an emerging factor in the pathophysiology and clinical management of ICC

Evaluation of the outcomes of staging laparoscopy in intrahepatic cholangiocarcinoma patients undergoing surgical resection: a multicenter retrospective study in China

Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments

Impact of occult hepatitis B virus infection and high-fat diet on hepatocellular carcinoma development

Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review